PL365904A1 - Combination therapy for estrogen-dependent disorders - Google Patents

Combination therapy for estrogen-dependent disorders

Info

Publication number
PL365904A1
PL365904A1 PL01365904A PL36590401A PL365904A1 PL 365904 A1 PL365904 A1 PL 365904A1 PL 01365904 A PL01365904 A PL 01365904A PL 36590401 A PL36590401 A PL 36590401A PL 365904 A1 PL365904 A1 PL 365904A1
Authority
PL
Poland
Prior art keywords
estrogen
combination therapy
dependent disorders
disorders
dependent
Prior art date
Application number
PL01365904A
Other languages
English (en)
Polish (pl)
Inventor
Dinesh Purandare
Original Assignee
Pharmacia & Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Company filed Critical Pharmacia & Upjohn Company
Publication of PL365904A1 publication Critical patent/PL365904A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL01365904A 2000-11-16 2001-11-06 Combination therapy for estrogen-dependent disorders PL365904A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71460500A 2000-11-16 2000-11-16

Publications (1)

Publication Number Publication Date
PL365904A1 true PL365904A1 (en) 2005-01-10

Family

ID=24870727

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01365904A PL365904A1 (en) 2000-11-16 2001-11-06 Combination therapy for estrogen-dependent disorders

Country Status (16)

Country Link
EP (1) EP1341549A2 (fr)
JP (1) JP2004536022A (fr)
KR (1) KR20030051828A (fr)
CN (1) CN1498112A (fr)
AU (1) AU2002230464A1 (fr)
BR (1) BR0115423A (fr)
CA (1) CA2428249A1 (fr)
CZ (1) CZ20031349A3 (fr)
EA (1) EA200300572A1 (fr)
IL (1) IL155817A0 (fr)
MX (1) MXPA03004195A (fr)
NO (1) NO20032206L (fr)
NZ (1) NZ525720A (fr)
PL (1) PL365904A1 (fr)
WO (1) WO2002039995A2 (fr)
ZA (1) ZA200303669B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9050378B2 (en) 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
GB0506759D0 (en) * 2005-04-02 2005-05-11 Medical Res Council Combination treatment methods
EP1891964A1 (fr) * 2006-08-08 2008-02-27 AEterna Zentaris GmbH Utilisation de doses initiales d'analogues de LHRH et doses de maintenance d'antagonistes de LHRH pour le traitement de cancers dépendant des hormones
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
JP2010524996A (ja) * 2007-04-23 2010-07-22 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト Ｂｒｃａ媒介性疾患における使用のための、プロゲステロン受容体拮抗薬と、ルテインホルモン放出ホルモン作動薬および拮抗薬との組み合わせ
CN101775054B (zh) * 2010-02-05 2012-12-26 常州佳尔科药业集团有限公司 4-羟基-4-烯-3-酮甾族化合物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9911582D0 (en) * 1999-05-18 1999-07-21 Pharmacia & Upjohn Spa Combined method of treatment comprising an aromatase inhibitor and a further biologically active compound
GB9930839D0 (en) * 1999-12-30 2000-02-16 Pharmacia & Upjohn Spa Process for treating gynecomastia

Also Published As

Publication number Publication date
NO20032206L (no) 2003-07-15
CA2428249A1 (fr) 2002-05-23
CZ20031349A3 (cs) 2004-05-12
EA200300572A1 (ru) 2004-06-24
WO2002039995A2 (fr) 2002-05-23
WO2002039995A9 (fr) 2003-02-06
BR0115423A (pt) 2005-12-13
CN1498112A (zh) 2004-05-19
IL155817A0 (en) 2003-12-23
EP1341549A2 (fr) 2003-09-10
AU2002230464A1 (en) 2002-05-27
KR20030051828A (ko) 2003-06-25
WO2002039995A3 (fr) 2003-05-01
NO20032206D0 (no) 2003-05-15
MXPA03004195A (es) 2003-09-22
NZ525720A (en) 2006-12-22
ZA200303669B (en) 2004-05-13
JP2004536022A (ja) 2004-12-02

Similar Documents

Publication Publication Date Title
GB0012671D0 (en) Therapeutic agents
GB0003397D0 (en) Therapeutic agents
GB0004003D0 (en) Therapeutic agents
GB0018473D0 (en) Therapeutic agents
EP1296697A4 (fr) Agents therapeutiques - i
GB0009606D0 (en) Therapeutic combinations
GB0017256D0 (en) Therapeutic agents
GB0028429D0 (en) Therapy
GB0027561D0 (en) Therapeutic agents
GB0005789D0 (en) Therapeutic agents
GB0007907D0 (en) Therapeutic agents
GB0012214D0 (en) Therapeutic agents
GB0008696D0 (en) Therapeutic agents
GB0000564D0 (en) Therapeutic agents
GB0023610D0 (en) Therapeutic agents
GB0017518D0 (en) Therapeutic agents
IL155817A0 (en) Combination therapy for estrogen-dependent disorders
GB0108485D0 (en) Combination therapy
GB0007376D0 (en) Therapeutic agents
GB0017543D0 (en) Therapeutic agents
GB0022988D0 (en) Therapeutic agents
GB0014135D0 (en) Combination therapy
GB0007740D0 (en) Combination therapy
GB0013927D0 (en) Combination therapy
GB0014133D0 (en) Combination therapy

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)